Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 6 Framingham-adjusted relative risks of future cardiovascular events according to baseline levels of high-sensitivity C-reactive protein <1, 1 to 3, and >3 mg/l in 10 major prospective cohort studies. Data from references 56–61,65. *Data from the Reykjavik study are shown in tertiles. ARIC = Atherosclerosis Risk in Communities Study; CHS = Cardiovascular Health Study; EPIC-Norfolk = Evaluation c7E3 for Prevention of Ischemic Complications–Norfolk Study; HPFS = Health Professionals Follow-Up Study; MONICA = Monitoring Trends and Developments in Cardiovascular Disease Study; NHS = National Health Study; PHS = Physicians Health Study; PIMA = Pima Indian Study; WHS = Women’s Health Study.
